Transglutaminase inhibition: possible therapeutic mechanisms to protect cells from death in neurological disorders

Journal Title: Insights in Biology and Medicine - Year 2017, Vol 1, Issue 1

Abstract

Transglutaminases are a family of Ca2+-dependent enzymes which catalyze post-translational modifications of proteins. The main activity of these enzymes is the cross-linking of glutaminyl residues of a protein/peptide substrate to lysyl residues of a protein/peptide co-substrate. In addition to lysyl residues, other second nucleophilic co-substrates may include monoamines or polyamines (to form mono-or bi-substituted/crosslinked adducts) or -OH groups (to form ester linkages). In absence of co-substrates, the nucleophile may be water, resulting in the net deamidation of the glutaminyl residue. Transglutaminase activity has been suggested to be involved in molecular mechanisms responsible for both physiological and pathological processes. In particular, transglutaminase activity has been shown to be responsible for human autoimmune diseases, and Celiac Disease is just one of them. Interestingly, neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease, supranuclear palsy, Huntington’s disease and other polyglutamine diseases, are characterized in part by aberrant cerebral transglutaminase activity and by increased cross-linked proteins in affected brains. Here we describe the possible molecular mechanisms by which these enzymes could be responsible for such diseases and the possible use of transglutaminase inhibitors for patients with diseases characterized by aberrant transglutaminase activity.

Authors and Affiliations

Rosaria Romano, Nicola Gaetano Gatta, Elenamaria Fioretti, Vittorio Gentile

Keywords

Related Articles

Medical bioethics vs. Medical ethics*

The current situation of bioethics illustrates what has become known as “the anthropological halt”, described with great lucidity by C. S. Lewis in his book The Abolition of Man as the neglect of the “Tao”, a not very ex...

Similarity between Some Biological Systems, Organotropism and Metastatic Process: Active Role Played By Secondary Organ?

According to literature, about 90% of death from cancer is related to metastasis. Metastatic process present many similarity to some other biological processes. Once we have examined some relevant biomedical literature,...

Maternal thyroid dysfunction and neonatal cardiac disorders

The normal levels of thyroid hormones (THs; thyroxine, T4 & 3,5,3′-triiodo-L-thyronine, T3) are necessary for the normal development [1-48], particularly the fetal and neonatal cardiac growth and development [49]. The ac...

Surface Plasmon Resonance technology to assess biological interactions

Molecular interactions between proteins or between proteins and small molecules are pivotal events for selective binding of biological structures and, consequentially, for their correct function. In this scenario, the ev...

The master regulator gene PRDM2 controls C2C12 myoblasts proliferation and Differentiation switch and PRDM4 and PRDM10 expression

The Positive Regulatory Domain (PRDM) protein family gene is involved in a spectrum variety of biological processes, including proliferation, differentiation and apoptosis: its member seem to be transcriptional regulator...

Download PDF file
  • EP ID EP556861
  • DOI 10.29328/journal.hjbm.1001004
  • Views 54
  • Downloads 0

How To Cite

Rosaria Romano, Nicola Gaetano Gatta, Elenamaria Fioretti, Vittorio Gentile (2017). Transglutaminase inhibition: possible therapeutic mechanisms to protect cells from death in neurological disorders. Insights in Biology and Medicine, 1(1), 26-38. https://europub.co.uk/articles/-A-556861